FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281712788> ?p ?o ?g. }

• W4281712788 endingPage "109682" @default.
• W4281712788 startingPage "109682" @default.
• W4281712788 abstract "Background: Diabetes Mellitus (DM) as a chronic disease makes some influence to all organic systems in the body. Some of these changes affect nervous system (different kinds of neuropathies), and some kind of immune response to these disorders could be expected. Michigan Neuropathy Screening Instrument (MNSI) is used to assess distal symmetrical peripheral neuropathy in DM. Aim: This research study aimed to assess the population of diabetic patients with MNSI and to check the influence of the duration of DM on the immune response. Inflammatory markers (CRP; Le; SE) and cytokines (IL-6, Il-1β, TNF-α, TGF-β) were used as a measure of the immune response. Method: The study included 100 participants with Diabetes Mellitus type 2 (men and women) and 30 healthy participants as a control group. All participants were examined through the regular examination in General Hospital Tešanj, BiH. The participants were divided into 3 groups, by criteria DMT2 duration and a control group. The first group included 32 participants with DMT2 less than 10 years duration (group A); second group included 35 participants 10-20 DMT2 duration (group B) and the third group included 33 participants more than 20 years DMT2 duration (group C). The control group included 30 healthy participants. All diabetic participants were examined by MNSI to check neuropathy status and to check distribution through the groups (sensitivity 93.3%, specificity 25%). Cut-off values of MNSI were: ≤2.5 points without neuropathy; 2.5-7- neuropathy I stage, ≥7.5 neuropathy stage II. The ELISA test was performed for the measurement of cytokines. Results: The results of MNSI examination have shown that: 7 diabetic participants had ≤2.5; 31 participants had 2.5-7 p, and 54 had ≥7.5. Groups A (n=4) and B (n=3) had a similar number of participants without neuropathy. Groups B (n=22) and C (n=20) had a similar number of participants with stage II neuropathy. No significant difference between groups in MNSI was found. Statistically significant correlations were found in group A between MNSI and IL-6 (R=0.402, p=0.025); IL-6 and CRP (R=0.784, p=0.0001); CRP and MNSI (R=0.500, p=0.034). No statistically significant correlations were found in B and C groups between MNSI and inflammatory markers. Also, statistically significant correlations were not found between HbA1C and MNSI, inflammatory markers and cytokines. Discussion: Previous studies conducted to assess the impact of hyperglycemia on diabetic neuropathy and the inflammatory environment in the body, have shown a positive correlation. However, there was no study that measured the impact of different periods of DM on these processes. This study is unique because the MNSI score showed a significant correlation with IL-6 and CRP only in the group of participants with less than 10 years of DM duration. MNSI examination showed an increase in the number of participants with neuropathy across groups, and according to these results a correlation with other inflammatory cytokines, especially TGF-β1, was expected. Subsequent studies should look at the effect of drugs on inflammatory cytokines, which treat glycaemia and concomitant diseases." @default.
• W4281712788 created "2022-06-13" @default.
• W4281712788 creator A5005085031 @default.
• W4281712788 creator A5014062361 @default.
• W4281712788 creator A5020367681 @default.
• W4281712788 creator A5020768339 @default.
• W4281712788 creator A5023068211 @default.
• W4281712788 creator A5038687492 @default.
• W4281712788 creator A5054067040 @default.
• W4281712788 creator A5067976089 @default.
• W4281712788 creator A5072187802 @default.
• W4281712788 creator A5084943315 @default.
• W4281712788 date "2022-04-01" @default.
• W4281712788 modified "2023-10-16" @default.
• W4281712788 title "IDF21-0423 Michigan neuropathy screening for assessing diabetes in participants and correlation to the immune response" @default.
• W4281712788 doi "https://doi.org/10.1016/j.diabres.2022.109682" @default.
• W4281712788 hasPublicationYear "2022" @default.
• W4281712788 type Work @default.
• W4281712788 citedByCount "4" @default.
• W4281712788 countsByYear W42817127882023 @default.
• W4281712788 crossrefType "journal-article" @default.
• W4281712788 hasAuthorship W4281712788A5005085031 @default.
• W4281712788 hasAuthorship W4281712788A5014062361 @default.
• W4281712788 hasAuthorship W4281712788A5020367681 @default.
• W4281712788 hasAuthorship W4281712788A5020768339 @default.
• W4281712788 hasAuthorship W4281712788A5023068211 @default.
• W4281712788 hasAuthorship W4281712788A5038687492 @default.
• W4281712788 hasAuthorship W4281712788A5054067040 @default.
• W4281712788 hasAuthorship W4281712788A5067976089 @default.
• W4281712788 hasAuthorship W4281712788A5072187802 @default.
• W4281712788 hasAuthorship W4281712788A5084943315 @default.
• W4281712788 hasBestOaLocation W42817127881 @default.
• W4281712788 hasConcept C126322002 @default.
• W4281712788 hasConcept C134018914 @default.
• W4281712788 hasConcept C1862650 @default.
• W4281712788 hasConcept C203014093 @default.
• W4281712788 hasConcept C2779178840 @default.
• W4281712788 hasConcept C2779901536 @default.
• W4281712788 hasConcept C2908647359 @default.
• W4281712788 hasConcept C555293320 @default.
• W4281712788 hasConcept C71924100 @default.
• W4281712788 hasConcept C8891405 @default.
• W4281712788 hasConcept C99454951 @default.
• W4281712788 hasConceptScore W4281712788C126322002 @default.
• W4281712788 hasConceptScore W4281712788C134018914 @default.
• W4281712788 hasConceptScore W4281712788C1862650 @default.
• W4281712788 hasConceptScore W4281712788C203014093 @default.
• W4281712788 hasConceptScore W4281712788C2779178840 @default.
• W4281712788 hasConceptScore W4281712788C2779901536 @default.
• W4281712788 hasConceptScore W4281712788C2908647359 @default.
• W4281712788 hasConceptScore W4281712788C555293320 @default.
• W4281712788 hasConceptScore W4281712788C71924100 @default.
• W4281712788 hasConceptScore W4281712788C8891405 @default.
• W4281712788 hasConceptScore W4281712788C99454951 @default.
• W4281712788 hasLocation W42817127881 @default.
• W4281712788 hasLocation W42817127882 @default.
• W4281712788 hasOpenAccess W4281712788 @default.
• W4281712788 hasPrimaryLocation W42817127881 @default.
• W4281712788 hasRelatedWork W168678571 @default.
• W4281712788 hasRelatedWork W2009472247 @default.
• W4281712788 hasRelatedWork W2161666981 @default.
• W4281712788 hasRelatedWork W2369376597 @default.
• W4281712788 hasRelatedWork W2599258583 @default.
• W4281712788 hasRelatedWork W2789566288 @default.
• W4281712788 hasRelatedWork W3209321612 @default.
• W4281712788 hasRelatedWork W4285154983 @default.
• W4281712788 hasRelatedWork W4385584652 @default.
• W4281712788 hasRelatedWork W3123348182 @default.
• W4281712788 hasVolume "186" @default.
• W4281712788 isParatext "false" @default.
• W4281712788 isRetracted "false" @default.
• W4281712788 workType "article" @default.